Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell H S Tan

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
Journal of the International AIDS Society|December 5, 2022
Intersecting HIV and mpox epidemics: more questions than answersNicolo Girometti, Dimie Ogoina, Darrell H S Tan, et al.
Patient Preference and Adherence|October 7, 2014
Acceptability of bone antiresorptive therapy among HIV-infected adults at different stages of antiretroviral therapyJillian Taras, Gordon Arbess, James Owen, et al.
Qualitative Health Research|May 26, 2022
"What other choices might I have made?": Sexual Minority Men, the PrEP Cascade and the Shifting Subjective Dimensions of HIV RiskMark Gaspar, Alex Wells, Mark Hull, et al.
Trials|September 30, 2020
Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxisDarrell H S Tan, Rupesh Agrawal, Ruanne V Barnabas, et al.
AIDS Patient Care and Stds|November 30, 2017
The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP UsersDaniel Grace, Jody Jollimore, Paul MacPherson, et al.
Plos One|January 6, 2026
A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-ScoreKim Engler, David Lessard, Serge Vicente, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 13, 2020
Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015-2018)Darrell H S Tan, Thomas M Dashwood, James Wilton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2018
Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV ExposuresEthan Tumarkin, Amila Heendeniya, Pauline Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2023
Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, CanadaMaxime J Billick, Karla N Fisher, Samantha Myers, et al.
HIV Research & Clinical Practice|February 29, 2020
Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trialDarrell H S Tan, Terry Lee, Janet Raboud, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Journal of the International AIDS Society|December 5, 2022
Intersecting HIV and mpox epidemics: more questions than answersNicolo Girometti, Dimie Ogoina, Darrell H S Tan, et al.
Patient Preference and Adherence|October 7, 2014
Acceptability of bone antiresorptive therapy among HIV-infected adults at different stages of antiretroviral therapyJillian Taras, Gordon Arbess, James Owen, et al.
Qualitative Health Research|May 26, 2022
"What other choices might I have made?": Sexual Minority Men, the PrEP Cascade and the Shifting Subjective Dimensions of HIV RiskMark Gaspar, Alex Wells, Mark Hull, et al.
Trials|September 30, 2020
Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxisDarrell H S Tan, Rupesh Agrawal, Ruanne V Barnabas, et al.
AIDS Patient Care and Stds|November 30, 2017
The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP UsersDaniel Grace, Jody Jollimore, Paul MacPherson, et al.
Plos One|January 6, 2026
A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-ScoreKim Engler, David Lessard, Serge Vicente, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 13, 2020
Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015-2018)Darrell H S Tan, Thomas M Dashwood, James Wilton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2018
Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV ExposuresEthan Tumarkin, Amila Heendeniya, Pauline Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2023
Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, CanadaMaxime J Billick, Karla N Fisher, Samantha Myers, et al.
HIV Research & Clinical Practice|February 29, 2020
Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trialDarrell H S Tan, Terry Lee, Janet Raboud, et al.
Pageof 15